Detalles de la búsqueda
1.
Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer.
BMC Med
; 20(1): 160, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35534835
2.
MicroRNA-4461 derived from bone marrow mesenchymal stem cell exosomes inhibits tumorigenesis by downregulating COPB2 expression in colorectal cancer.
Biosci Biotechnol Biochem
; 84(2): 338-346, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31631786
3.
Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma.
J Cancer
; 15(9): 2691-2711, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577601
4.
Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs.
Thorac Cancer
; 13(9): 1289-1298, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347870
5.
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer.
Thorac Cancer
; 13(21): 2951-2959, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126963
6.
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib.
Transl Oncol
; 14(9): 101163, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192651
Resultados
1 -
6
de 6
1
Próxima >
>>